BIOMAT Database Logo BIOMAT Database Logo

[Comparison of mexiletine and dihydroquinidine in the treatment of ventricular asystolic arrhythmia]. 1985

D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon

UI MeSH Term Description Entries
D008297 Male Males
D008801 Mexiletine Antiarrhythmic agent pharmacologically similar to LIDOCAINE. It may have some anticonvulsant properties. KO-1173,KO1173,KOE-1173,Mexiletene,Mexiletine Hydrochloride,Mexitil,Mexitil PL,Mexityl,Novo-Mexiletine,KO 1173,KOE 1173,KOE1173,Novo Mexiletine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011437 Propylamines Derivatives of propylamine (the structural formula NH2CH2CH2CH3).
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005117 Cardiac Complexes, Premature A group of cardiac arrhythmias in which the cardiac contractions are not initiated at the SINOATRIAL NODE. They include both atrial and ventricular premature beats, and are also known as extra or ectopic heartbeats. Their frequency is increased in heart diseases. Ectopic Heartbeats,Extrasystole,Premature Beats,Premature Cardiac Complexes,Cardiac Complex, Premature,Extrasystoles,Premature Cardiac Complex,Beat, Premature,Beats, Premature,Complexes, Premature Cardiac,Ectopic Heartbeat,Heartbeat, Ectopic,Heartbeats, Ectopic,Premature Beat,Premature Cardiac Complices

Related Publications

D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
[Mexiletine, a new anti-arrhythmic, in the treatment of ventricular arrhythmia].
January 1982, La Clinica terapeutica,
D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
[Mexiletine in the treatment of arrhythmia].
August 1982, Polski tygodnik lekarski (Warsaw, Poland : 1960),
D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
[Mexiletine in the treatment of arrhythmia].
September 1983, Polski tygodnik lekarski (Warsaw, Poland : 1960),
D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
Long-term mexiletine for ventricular arrhythmia.
May 1984, American heart journal,
D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
[Long-term mexiletine treatment of ventricular arrhythmia in patients after myocardial infarction].
March 1992, Polskie Archiwum Medycyny Wewnetrznej,
D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
[Severe ventricular arrhythmia in childhood treated with mexiletine].
June 1984, La Clinica terapeutica,
D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
[Treatment of ventricular arrhythmia with mexiletine (Mexitil), monitored by Holter ambulatory electrocardiography].
April 1988, Minerva cardioangiologica,
D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
Mexiletine. Use in control of chronic drug-resistant ventricular arrhythmia.
July 1979, JAMA,
D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
[The effects and pharmacokinetics of mexiletine in ventricular arrhythmia in maintenance hemodialysis patients].
August 1987, Nihon Jinzo Gakkai shi,
D Accettura, and L De Toma, and R Lagioia, and F Mastropasqua, and S G Mangini, and D Scrutinio, and P Rizzon
Mexiletine therapy in a child with a chronic ventricular arrhythmia.
January 1977, Postgraduate medical journal,
Copied contents to your clipboard!